Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7543 |
Intermediate Similarity |
NPD2433 |
Clinical (unspecified phase) |
0.7422 |
Intermediate Similarity |
NPD2778 |
Approved |
0.7382 |
Intermediate Similarity |
NPD3945 |
Discontinued |
0.7373 |
Intermediate Similarity |
NPD6974 |
Phase 3 |
0.7325 |
Intermediate Similarity |
NPD2779 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5924 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD5443 |
Clinical (unspecified phase) |
0.7269 |
Intermediate Similarity |
NPD5850 |
Phase 3 |
0.722 |
Intermediate Similarity |
NPD6247 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD1505 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1867 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2951 |
Discontinued |
0.7106 |
Intermediate Similarity |
NPD1166 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD3250 |
Phase 1 |
0.7034 |
Intermediate Similarity |
NPD2081 |
Clinical (unspecified phase) |
0.6917 |
Remote Similarity |
NPD4667 |
Clinical (unspecified phase) |
0.688 |
Remote Similarity |
NPD7393 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD6525 |
Clinical (unspecified phase) |
0.685 |
Remote Similarity |
NPD7417 |
Discontinued |
0.6827 |
Remote Similarity |
NPD5479 |
Discontinued |
0.6827 |
Remote Similarity |
NPD4898 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD7268 |
Clinical (unspecified phase) |
0.6809 |
Remote Similarity |
NPD7690 |
Clinical (unspecified phase) |
0.6793 |
Remote Similarity |
NPD3507 |
Phase 2 |
0.6781 |
Remote Similarity |
NPD772 |
Phase 3 |
0.6761 |
Remote Similarity |
NPD7547 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD3392 |
Approved |
0.6721 |
Remote Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD7180 |
Phase 3 |
0.6707 |
Remote Similarity |
NPD3263 |
Phase 3 |
0.6693 |
Remote Similarity |
NPD7853 |
Phase 2 |
0.668 |
Remote Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3809 |
Discontinued |
0.6653 |
Remote Similarity |
NPD6567 |
Clinical (unspecified phase) |
0.664 |
Remote Similarity |
NPD7031 |
Phase 1 |
0.6639 |
Remote Similarity |
NPD5293 |
Phase 2 |
0.6628 |
Remote Similarity |
NPD6716 |
Phase 1 |
0.6615 |
Remote Similarity |
NPD5817 |
Discontinued |
0.6611 |
Remote Similarity |
NPD6138 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6598 |
Remote Similarity |
NPD7467 |
Discontinued |
0.6591 |
Remote Similarity |
NPD5532 |
Phase 2 |
0.6576 |
Remote Similarity |
NPD4394 |
Clinical (unspecified phase) |
0.6571 |
Remote Similarity |
NPD1955 |
Discontinued |
0.6564 |
Remote Similarity |
NPD4322 |
Discontinued |
0.6564 |
Remote Similarity |
NPD7022 |
Phase 2 |
0.6559 |
Remote Similarity |
NPD4429 |
Discontinued |
0.6555 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6555 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD3801 |
Clinical (unspecified phase) |
0.6549 |
Remote Similarity |
NPD4460 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD6745 |
Discontinued |
0.6537 |
Remote Similarity |
NPD4368 |
Phase 2 |
0.6535 |
Remote Similarity |
NPD1466 |
Phase 3 |
0.6535 |
Remote Similarity |
NPD1467 |
Approved |
0.652 |
Remote Similarity |
NPD2285 |
Clinical (unspecified phase) |
0.652 |
Remote Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.6519 |
Remote Similarity |
NPD8357 |
Approved |
0.6518 |
Remote Similarity |
NPD6719 |
Approved |
0.6515 |
Remote Similarity |
NPD6245 |
Phase 2 |
0.6498 |
Remote Similarity |
NPD3006 |
Discontinued |
0.6496 |
Remote Similarity |
NPD5022 |
Discontinued |
0.6494 |
Remote Similarity |
NPD7279 |
Phase 2 |
0.6494 |
Remote Similarity |
NPD7278 |
Phase 2 |
0.6491 |
Remote Similarity |
NPD5857 |
Phase 3 |
0.649 |
Remote Similarity |
NPD5866 |
Approved |
0.6483 |
Remote Similarity |
NPD5512 |
Phase 3 |
0.6462 |
Remote Similarity |
NPD6790 |
Phase 1 |
0.6455 |
Remote Similarity |
NPD8461 |
Discontinued |
0.6449 |
Remote Similarity |
NPD6220 |
Phase 3 |
0.6449 |
Remote Similarity |
NPD5416 |
Discontinued |
0.6449 |
Remote Similarity |
NPD7703 |
Clinical (unspecified phase) |
0.6438 |
Remote Similarity |
NPD1898 |
Discontinued |
0.6437 |
Remote Similarity |
NPD7538 |
Clinical (unspecified phase) |
0.6431 |
Remote Similarity |
NPD4952 |
Phase 3 |
0.6431 |
Remote Similarity |
NPD1659 |
Phase 1 |
0.6426 |
Remote Similarity |
NPD7395 |
Discontinued |
0.642 |
Remote Similarity |
NPD5429 |
Discontinued |
0.6415 |
Remote Similarity |
NPD5482 |
Discontinued |
0.6412 |
Remote Similarity |
NPD6495 |
Clinical (unspecified phase) |
0.6407 |
Remote Similarity |
NPD6530 |
Approved |
0.6407 |
Remote Similarity |
NPD6531 |
Approved |
0.6407 |
Remote Similarity |
NPD7708 |
Approved |
0.6405 |
Remote Similarity |
NPD3946 |
Clinical (unspecified phase) |
0.6404 |
Remote Similarity |
NPD6252 |
Clinical (unspecified phase) |
0.6388 |
Remote Similarity |
NPD7206 |
Clinical (unspecified phase) |
0.6387 |
Remote Similarity |
NPD7924 |
Phase 2 |
0.6387 |
Remote Similarity |
NPD7925 |
Phase 2 |
0.6379 |
Remote Similarity |
NPD3842 |
Clinical (unspecified phase) |
0.6371 |
Remote Similarity |
NPD3257 |
Approved |
0.6371 |
Remote Similarity |
NPD1638 |
Discovery |
0.6364 |
Remote Similarity |
NPD6460 |
Clinical (unspecified phase) |
0.636 |
Remote Similarity |
NPD5632 |
Approved |
0.636 |
Remote Similarity |
NPD7886 |
Phase 2 |
0.636 |
Remote Similarity |
NPD7885 |
Phase 2 |
0.6357 |
Remote Similarity |
NPD4373 |
Phase 2 |
0.6353 |
Remote Similarity |
NPD6475 |
Phase 2 |
0.6352 |
Remote Similarity |
NPD7043 |
Discontinued |
0.6348 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6346 |
Remote Similarity |
NPD4846 |
Phase 2 |
0.6345 |
Remote Similarity |
NPD6550 |
Discontinued |
0.6339 |
Remote Similarity |
NPD3925 |
Approved |
0.6335 |
Remote Similarity |
NPD3258 |
Approved |
0.6333 |
Remote Similarity |
NPD6874 |
Approved |
0.6328 |
Remote Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.6326 |
Remote Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.6324 |
Remote Similarity |
NPD6209 |
Approved |
0.6314 |
Remote Similarity |
NPD7803 |
Approved |
0.631 |
Remote Similarity |
NPD6242 |
Discontinued |
0.6302 |
Remote Similarity |
NPD5488 |
Discontinued |
0.6298 |
Remote Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.6295 |
Remote Similarity |
NPD7053 |
Clinical (unspecified phase) |
0.6295 |
Remote Similarity |
NPD6568 |
Discontinued |
0.6289 |
Remote Similarity |
NPD7994 |
Phase 2 |
0.6285 |
Remote Similarity |
NPD4923 |
Phase 1 |
0.6283 |
Remote Similarity |
NPD8463 |
Approved |
0.6279 |
Remote Similarity |
NPD7688 |
Phase 1 |
0.6278 |
Remote Similarity |
NPD8358 |
Approved |
0.6275 |
Remote Similarity |
NPD8279 |
Clinical (unspecified phase) |
0.6275 |
Remote Similarity |
NPD5726 |
Clinical (unspecified phase) |
0.627 |
Remote Similarity |
NPD2785 |
Clinical (unspecified phase) |
0.626 |
Remote Similarity |
NPD6376 |
Discontinued |
0.6255 |
Remote Similarity |
NPD4989 |
Phase 2 |
0.625 |
Remote Similarity |
NPD7392 |
Phase 2 |
0.625 |
Remote Similarity |
NPD7490 |
Discontinued |
0.6236 |
Remote Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.6236 |
Remote Similarity |
NPD8016 |
Phase 3 |
0.623 |
Remote Similarity |
NPD6198 |
Phase 1 |
0.623 |
Remote Similarity |
NPD7597 |
Clinical (unspecified phase) |
0.6226 |
Remote Similarity |
NPD4328 |
Approved |
0.6221 |
Remote Similarity |
NPD4958 |
Clinical (unspecified phase) |
0.6215 |
Remote Similarity |
NPD7475 |
Clinical (unspecified phase) |
0.6208 |
Remote Similarity |
NPD6347 |
Phase 2 |
0.6206 |
Remote Similarity |
NPD2884 |
Phase 1 |
0.6201 |
Remote Similarity |
NPD5922 |
Phase 3 |
0.6194 |
Remote Similarity |
NPD3853 |
Clinical (unspecified phase) |
0.6194 |
Remote Similarity |
NPD6593 |
Clinical (unspecified phase) |
0.6194 |
Remote Similarity |
NPD1936 |
Clinical (unspecified phase) |
0.6189 |
Remote Similarity |
NPD1483 |
Discontinued |
0.618 |
Remote Similarity |
NPD8100 |
Phase 3 |
0.6179 |
Remote Similarity |
NPD5499 |
Approved |
0.6175 |
Remote Similarity |
NPD5417 |
Clinical (unspecified phase) |
0.6175 |
Remote Similarity |
NPD6169 |
Phase 1 |
0.6174 |
Remote Similarity |
NPD4613 |
Phase 2 |
0.6166 |
Remote Similarity |
NPD1926 |
Approved |
0.6163 |
Remote Similarity |
NPD5513 |
Phase 2 |
0.6163 |
Remote Similarity |
NPD7064 |
Clinical (unspecified phase) |
0.6162 |
Remote Similarity |
NPD7416 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD7284 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD6962 |
Phase 2 |
0.6154 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6151 |
Remote Similarity |
NPD9243 |
Approved |
0.6148 |
Remote Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.6147 |
Remote Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.6145 |
Remote Similarity |
NPD7862 |
Clinical (unspecified phase) |
0.6144 |
Remote Similarity |
NPD5256 |
Discontinued |
0.6142 |
Remote Similarity |
NPD3875 |
Discontinued |
0.6138 |
Remote Similarity |
NPD4465 |
Phase 2 |
0.6138 |
Remote Similarity |
NPD4467 |
Phase 2 |
0.6137 |
Remote Similarity |
NPD5450 |
Discontinued |
0.6134 |
Remote Similarity |
NPD8102 |
Discontinued |
0.6134 |
Remote Similarity |
NPD4369 |
Phase 2 |
0.6131 |
Remote Similarity |
NPD7955 |
Approved |
0.6131 |
Remote Similarity |
NPD7956 |
Approved |
0.613 |
Remote Similarity |
NPD3746 |
Discontinued |
0.6124 |
Remote Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.6124 |
Remote Similarity |
NPD5640 |
Discontinued |
0.6124 |
Remote Similarity |
NPD7051 |
Phase 3 |
0.6122 |
Remote Similarity |
NPD7627 |
Approved |
0.6122 |
Remote Similarity |
NPD7626 |
Approved |
0.6116 |
Remote Similarity |
NPD5003 |
Discontinued |
0.6115 |
Remote Similarity |
NPD7589 |
Clinical (unspecified phase) |
0.6115 |
Remote Similarity |
NPD7673 |
Phase 3 |
0.6113 |
Remote Similarity |
NPD8403 |
Phase 1 |
0.6111 |
Remote Similarity |
NPD8101 |
Phase 3 |
0.6107 |
Remote Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD7592 |
Phase 2 |
0.6103 |
Remote Similarity |
NPD2311 |
Clinical (unspecified phase) |
0.6102 |
Remote Similarity |
NPD7292 |
Approved |
0.61 |
Remote Similarity |
NPD4418 |
Discontinued |
0.61 |
Remote Similarity |
NPD3259 |
Approved |
0.6096 |
Remote Similarity |
NPD7069 |
Discontinued |
0.6089 |
Remote Similarity |
NPD7452 |
Approved |
0.6089 |
Remote Similarity |
NPD7222 |
Phase 2 |
0.6089 |
Remote Similarity |
NPD7453 |
Approved |
0.6085 |
Remote Similarity |
NPD7681 |
Clinical (unspecified phase) |
0.6078 |
Remote Similarity |
NPD3514 |
Clinical (unspecified phase) |
0.6078 |
Remote Similarity |
NPD7203 |
Clinical (unspecified phase) |
0.6077 |
Remote Similarity |
NPD7654 |
Discontinued |
0.6075 |
Remote Similarity |
NPD6825 |
Phase 1 |
0.607 |
Remote Similarity |
NPD6995 |
Phase 1 |
0.6063 |
Remote Similarity |
NPD3949 |
Clinical (unspecified phase) |
0.6059 |
Remote Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.6057 |
Remote Similarity |
NPD5848 |
Clinical (unspecified phase) |
0.6056 |
Remote Similarity |
NPD7070 |
Clinical (unspecified phase) |
0.6055 |
Remote Similarity |
NPD8479 |
Phase 2 |
0.6054 |
Remote Similarity |
NPD8052 |
Clinical (unspecified phase) |
0.6051 |
Remote Similarity |
NPD5867 |
Clinical (unspecified phase) |
0.605 |
Remote Similarity |
NPD5459 |
Phase 2 |
0.605
|
Remote Similarity |
NPD6393 |
Clinical (unspecified phase) |